Stem cells - Strategic Insights Report (Page 4)

Cancer

Modified Vesicles Show Promise in Gastric Cancer Treatment

Researchers at the Aoyang Institute of Cancer have developed a new approach to treating gastric cancer using modified vesicles derived from human umbilical cord mesenchymal stem cells. The study, published in the Journal of Controlled Release, found that these modified vesicles, known as Neu/MSC-sEVs, were able to effectively inhibit

Adult respiratory distress syndrome

Mesenchymal Stem Cells Derived Extracellular Vesicles Hold Promise for Acute Lung Injury Treatment

Acute Respiratory Distress Syndrome (ARDS) is a life-threatening condition characterized by inflammation and lung damage. Researchers have been exploring alternative treatments, including the use of extracellular vesicles derived from mesenchymal stem cells (MSCs). A recent study published in Pharmaceutics has shed light on the potential of MSC-derived extracellular vesicles in

See all